key: cord-0770734-x9pgcdcw
authors: Mohapatra, Prasanta Raghab; Mishra, Baijayantimala; Behera, Bijayini
title: Immunity and protection from COVID‐19—Environmental mycobacteria play a role
date: 2020-06-29
journal: J Med Virol
DOI: 10.1002/jmv.26214
sha: c7a0fed23aea3788f218fdc6d19968d9a31e35e2
doc_id: 770734
cord_uid: x9pgcdcw

Kerboua et al1 discussed about the immunity induced by nonspecific inflammation and BCG (Bacillus Calmette-Guerin) as factors altering the susceptibility to severe illness from coronavirus disease 2019 (COVID-19). Ozdemir et al2 in their study have shown proportionately less number of cases, milder illness and a lower death rate in BCG vaccinated population as compared to BCG non-vaccinated across different countries and hemispheres.2 This article is protected by copyright. All rights reserved.

Immunity and protection from COVID-19-Environmental mycobacteria play a role In the TB endemic countries like India with high population density, the environmental mycobacteria seems to play a role as over half of the population are usually positive for tuberculin skin test (TST). Factually these conditions impact some degree of general immunity for new infections. The development of nonspecific (off-target) partial immunity is likely from environmental mycobacteria as people from TB endemic countries like India get infected from the environment time to time.

Possibly it is one of the reason most of the people become TST positive. 6 It is a plausible hypothesis that environmental mycobacteria like non-tuberculous mycobacteria (NTM) are imparting similar to BCG but sustained nonspecific immunological response that may be correlated with reduced disease burden and severity of COVID-19. The ubiquitous persistence of NTM contributes to impart immune responses, whose effect is measured by positive TST particularly in BCG-nonvaccinated population. It is also hypothesized that environmental mycobacteria induce repeated alteration in the immune system resulting increased level of innate and adaptive or trained immunity. The environmental mycobacteria might have induced trained immunity making epigenetic alterations in the similar mechanism as described for BCG. 7 It is likely that the environmental mycobacteria play a role beyond the protection of BCG and more importantly for nonvaccinated people. This hypothesis can support the concept of partial protection from COVID-19 in countries where BCG vaccination not routine. However further study needed to confirm the hypothesis.

In fact, repeated exposure to environmental mycobacteria is presumed to be the explanation for the low efficacy of BCG vaccination particularly in tropical regions. Furthermore, because of crossreactivity among mycobacterial species, exposure to environmental mycobacteria may provide some protection against TB, and also it can induce positive TST. 8 TB endemicity or environmental mycobacteria seems to be correlated with reduced disease burden and severity of COVID-19.

It is possible that people of the TB endemic countries like India despite vast population and growing numbers of COVID19 infection, have acquired some protections from severity and deaths from COVID-19 in comparison to TB non-endemic countries (like Europe and USA). Although it appears that such nonspecific immunity may not able to stop COVID 19 infections, but is likely to diminish its impact on severity of COVID-19. 

The perplexing question of trained immunity versus adaptive memory in COVID-19

Is BCG vaccination affecting the spread and severity of COVID-19? Allergy

Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis

Nonspecific effects of BCG vaccine on viral infections

CTRIUMPH study team. Tuberculin skin test and QuantiFERON-Gold in tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting

Neonatal bacillus Calmette-Guerin vaccination and environmental mycobacteria in sensitizing antimycobacterial activity of macrophages

Development of the mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree

Nontuberculous mycobacteria: clinical importance and relevance to bacille Calmette-Guérin vaccination

http://orcid.org/0000-0002-6625-2417